Skip to main content
. 2022 Apr 21;35(4):1283–1287. doi: 10.1007/s40620-022-01330-z

Fig. 2.

Fig. 2

Kinetics of HLA-DR+ leukocytes. A, B Monitoring of HLA-DR+ monocytes (CD14+ HLA-DR+) and HLA-DR+ T lymphocytes (CD3+ HLA-DR+) over 2 weeks after the first CYC infusion. CYC cyclophosphamide